H.R. 5333 · 116th Congress

Ensuring Patient Access to Critical Breakthrough Products Act of 2019

Stage
In committee
Introduced
2019-12-06
Latest action
2019-12-09 · Referred to the Subcommittee on Health.

Action history

  1. 2019-12-09Referred to the Subcommittee on Health.
  2. 2019-12-06Introduced in House
  3. 2019-12-06Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. 2019-12-06Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.